Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

head and neck cancer

  • Clinical Evaluation of Deep Learning for Tumor Delineation on <sup>18</sup>F-FDG PET/CT of Head and Neck Cancer
    Open Access
    Clinical Evaluation of Deep Learning for Tumor Delineation on 18F-FDG PET/CT of Head and Neck Cancer
    David G. Kovacs, Claes N. Ladefoged, Kim F. Andersen, Jane M. Brittain, Charlotte B. Christensen, Danijela Dejanovic, Naja L. Hansen, Annika Loft, Jørgen H. Petersen, Michala Reichkendler, Flemming L. Andersen and Barbara M. Fischer
    Journal of Nuclear Medicine April 1, 2024, 65 (4) 623-629; DOI: https://doi.org/10.2967/jnumed.123.266574
  • Imaging of Tumor Stroma Using <sup>68</sup>Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial
    Open Access
    Imaging of Tumor Stroma Using 68Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial
    Bingxin Gu, Ziyi Yang, Xinyue Du, Xiaoping Xu, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 365-371; DOI: https://doi.org/10.2967/jnumed.123.266556
  • You have access
    18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
    Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
  • <sup>89</sup>Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
    You have access
    89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
    Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen, Sjoukje F. Oosting, Adrienne H. Brouwers, Iris H.C. Miedema, Jens Voortman, Willemien C. Menke-van der Houven van Oordt, Ronald Boellaard, Dennis Vriens, Marije Slingerland, Rick Hermsen, Ilse van Engen-van Grunsven, Sandra Heskamp and Carla M.L. van Herpen
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1523-1530; DOI: https://doi.org/10.2967/jnumed.121.263470
  • <sup>18</sup>F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
    You have access
    18F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
    Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers and Joel Castelli
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1378-1385; DOI: https://doi.org/10.2967/jnumed.121.262891
  • Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma
    Open Access
    Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma
    Giri Krishnan, Nynke S. van den Berg, Naoki Nishio, Shrey Kapoor, Jaqueline Pei, Laura Freeman, Yu-Jin Lee, Quan Zhou, Stan van Keulen, Shayan Farkurnejad, James Condon, Fred M. Baik, Brock A. Martin and Eben L. Rosenthal
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1162-1168; DOI: https://doi.org/10.2967/jnumed.121.262235
  • Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with <sup>18</sup>F-FDG PET/CT: A Single-Center Prospective Study
    You have access
    Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study
    Louise M. Risør, Malene M. Clausen, Zaza Ujmajuridze, Mohammed Farhadi, Kim F. Andersen, Annika Loft, Jeppe Friborg and Andreas Kjaer
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1169-1176; DOI: https://doi.org/10.2967/jnumed.121.262866
  • Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
    Open Access
    Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
    Jasper Vonk, Jaron G. de Wit, Floris J. Voskuil, Yang Hang Tang, Wouter T.R. Hooghiemstra, Matthijs D. Linssen, Evert van den Broek, Jan J. Doff, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bert van der Vegt, Gooitzen M. van Dam and Max J.H. Witjes
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 672-678; DOI: https://doi.org/10.2967/jnumed.121.262530
  • You have access
    Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody–Dye Conjugate
    Naoki Nishio, Nynke S. van den Berg, Brock A. Martin, Stan van Keulen, Shayan Fakurnejad, Eben L. Rosenthal and Katheryne E. Wilson
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 648-655; DOI: https://doi.org/10.2967/jnumed.120.245241
  • You have access
    Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy
    Daniela Thorwarth, Stefan Welz, David Mönnich, Christina Pfannenberg, Konstantin Nikolaou, Matthias Reimold, Christian La Fougère, Gerald Reischl, Paul-Stefan Mauz, Frank Paulsen, Markus Alber, Claus Belka and Daniel Zips
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1698-1704; DOI: https://doi.org/10.2967/jnumed.119.227744

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire